| Name | Title | Contact Details |
|---|
Whether you travel because you want to or because you have to, being away from home shouldn`t mean pressing pause on life. With the comforts of the community, the pleasures of home, and the perks of prime locations, The Guild lets you keep on living your best life--no matter where the road takes you.
Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla`s next-generation Multiplex Crystal Digital PCR™ technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world`s first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, Infectious Disease & COVID-19 Research, and Wastewater and Environmental Testing and many more applications. Stilla aims to make Digital PCR a lab commodity in all life sciences areas including research, therapeutics, and the omics.
As a leading national healthcare solutions organization, Premier, Inc. collaborates with healthcare organizations to improve supply chain management, decrease healthcare costs, integrate data and improve the health of communities. As an industry leader, Premier has created one of the most comprehensive database of actionable data, best practices and cost reduction strategies. We enable our members to collaborate easily and efficiently improve their quality outcomes, while reducing costs. By engaging members and revealing new opportunities, we empower our alliance to improve performance like no one else in healthcare can.
Advanced Vascular Dynamics is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Decade of Discovery is a major research initiative led by the Minnesota Partnership for Biotechnology and Medical Genomics focused on preventing, optimally treating and ultimately curing diabetes.